Evidence map›Paper›PMID 40548379›Full record

ArticleJCI insight2025

An insider's guide to understanding and obtaining an NIH K career development award.

Don C Rockey, Kyu Y Rhee, Christopher S Williams, Jatin M Vyas, Charles W Emala, Emily J Gallagher

Abstract read
In one paragraph

Article in JCI insight, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Don C RockeyDigestive Disease Research Center, Medical University of South Carolina, Charleston, South Carolina, USA.
Kyu Y RheeDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
Christopher S WilliamsDivision of Gastroenterology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Jatin M VyasDivision of Infectious Disease, Department of Medicine, and.
Charles W EmalaDepartment of Anesthesiology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Emily J GallagherDivision of Endocrinology, Diabetes and Bone Disease, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Funding

The role of SMAD1 and SATB2 in colon patterningP20GM130457 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Hailong Zhang · 2020 to 2026
$18.7M
Proteomics CoreP30DK123704 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI DON C. ROCKEY · 2020 to 2026
$8.8M
Medical Scientist Training ProgramT32GM152284 · NIGMS · VANDERBILT UNIVERSITY · PI Christopher S. Williams · 2024 to 2026
$4.8M
Vanderbilt Stimulating Access to Research in Residency (V-StARR)R38HL167237 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Michael R. DeBaun, Christopher S. Williams · 2023 to 2026
$1.8M
Tri-I Stimulating Access to Research in Residency program (Tri-I StARR - NIAID)R38AI174255 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI CESARMAN, ETHEL, PERMAR, SALLIE R. · 2023 to 2025
$1.3M
Mount Sinai StARR Program - NIAIDR38AI181012 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BENJAMIN K CHEN, Jaime C Chu · 2024 to 2026
$918k
Mount Sinai StARR Program - NHLBIR38HL172261 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Jaime C Chu, Emily Jane Gallagher · 2024 to 2026
$918k
Medical University of South Carolina Mentoring Program in Digestive and Liver DiseasesUE5DK137316 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI DON C. ROCKEY · 2023 to 2026
$645k
NHLBI NIH HHS R38 HL167237NHLBI NIH HHS R38 HL172261NIAID NIH HHS R38 AI174255NIAID NIH HHS R38 AI181012NIDDK NIH HHS P30 DK123704NIDDK NIH HHS UE5 DK137316NIGMS NIH HHS P20 GM130457NIGMS NIH HHS T32 GM152284
6 · The paper itself

Abstract

Physician-scientists in academic medical centers require extramural grant support to launch and maintain their research careers. In order to cultivate the next generation of biomedical researchers, including physician-scientists, the NIH supports multiple career development (K series) awards. For many, their first experience in grant writing is composing a career development award (CDA) application. From the applicant's perspective, this process can be difficult. For one, NIH institute-specific differences between the same K mechanism can be confusing. Additionally, the importance of the various elements that make up the K application are frequently misunderstood. Furthermore, many K applications will not be funded on the initial submission; therefore, the need to resubmit an application should not be viewed as a sign of failure, but rather can be viewed as an element of resilience in biomedical research. In this piece, we aim to provide guidance for aspiring K applicants - in particular, from the reviewer perspective - with the intent of making the application process more understandable. We offer dos and don'ts on different components of the K application, advice on when to reach out to a program officer, and tips on resubmission. Our overarching goal is to provide support for prospective K applicants in their effort to obtain a K award. While targeted to K applications, most of the contents of this summary apply to any CDA.

Indexed as

Awards and PrizesBiomedical ResearchCareer MobilityResearch PersonnelAcademic Medical CentersHumansNational Institutes of Health (U.S.)United States

Identifiers

PMID40548379
PMCPMC12220936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.